21 May 2009
Optimal MPA, MPAG levels at the early period after kidney transplantation as the key contributors to improving long-term outcomes
T Baczkowska, A Sadowska, J Majchrzak, A Perkowska-Ptasińska, Z Lewandowski, T Cieciura, J Pazik, E Ważna, E Nowacka Cieciura, A Chmura, M DurlikAnn Transplant 2009; 14(1): 22-22 :: ID: 880277
Abstract
Background: Suboptimal MPA, MPAG levels are associated with significant
increases in graft loss. Purpose: to assess the influence of MPA, MPAG - Co
levels on GFR level and histological changes in the protocol biopsies in kidney allograft recipients.
Material/Methods: In a prospective study of 42 low-risk patients receiving MMF,
prednisone and a low or normal CsA dose we performed histological assessment according to Banff'97 classification in protocol biopsies before Tx and then at 3, 12, 36 months after Tx, we also assessed GFR at 1, 3, 12, 36 and 60 months after Tx and MPA (ELISA), MPAG (HPLC/UV) Co levels at day 7 and at 1, 3, 12, 36 months after Tx. Statistical analysis was performed with the aid of Generalized Additive Models (SAS System) and Spearman correlation.
Results: We observed significant relationships between MPA, MPAG Co levels and the subclinical rejection episodes (SCR), ci, ct, ah, CAN in the protocol biopsies at 36 month after Tx. In detail: MPA Co level at day 7 after Tx below 1.5 μg/mL was associated with increased risk of SCR (pnl<0.03), ci ≥2 (pnl<0.05), CAN ≥2 (pnl <0.04) and with ah ≥2 (pnl<0.07). MPAG Co level at day 7 after Tx above 100-150 μg/mL was associated with decreased risk of ct ≥2 (pnl <0.01), ci ≥2 (pnl <0.04), CAN ≥2 (pnl <0.04). We also observed significant positive correlations between MPA Co level and negative significant correlations
between MPAG Co level at 1 month after Tx and GFR at 1, 3, 12 and 36 month after Tx.
Conclusions: Optimal MPA exposure in the early post-transplant period may improve renal graft outcomes
Keywords: Immunosuppression, Kidney Transplantation
In Press
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
18 Mar 2024 : Original article
Does Antibiotic Use Increase the Risk of Post-Transplantation Diabetes Mellitus? A Retrospective Study of R...Ann Transplant In Press; DOI: 10.12659/AOT.943282
20 Mar 2024 : Original article
Transplant Nephrectomy: A Comparative Study of Timing and Techniques in a Single InstitutionAnn Transplant In Press; DOI: 10.12659/AOT.942252
28 Mar 2024 : Original article
Association Between FEV₁ Decline Rate and Mortality in Long-Term Follow-Up of a 21-Patient Pilot Clinical T...Ann Transplant In Press; DOI: 10.12659/AOT.942823
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860